ENTITY

Physiomics (PYC LN)

34
Analysis
Industrials • United Kingdom
Physiomics is a data-driven consultancy that provides Model-Informed Drug Development (MIDD), Biostatistics, Statistical Programming, and Bioinformatics solutions to biopharmaceutical companies and research institutes. The company utilizes its proprietary Virtual Tumour technology platform to optimize the design of cancer clinical trials and predict the effects of treatments. Physiomics was founded in 2001 and is headquartered in Abingdon, United Kingdom.
more
bullish•Physiomics
•24 Jun 2025 00:04•Issuer-paid

Hybridan Research: Physiomics plc: Synergistic Services

A further two contracts worth a combined £111,000 were announced this morning by the Company, as the total revenue pipeline continues to...

Logo
Hybridan
340 Views
Share
bullish•Smarttech247
•05 Jun 2025 22:04•Issuer-paid

Smarttech247 Group PLC - Hybridan Small Cap Feast: 29/05/2025

Our daily digest of news from UK Small Caps 29th May 2025 @HybridanLLP * A corporate client of...

Logo
Hybridan
357 Views
Share
bullish•Physiomics
•05 Jun 2025 22:04•Issuer-paid

Hybridan Research: Physiomics plc: Building Relationships

A contract extension has been signed with an existing large pharma client. This builds upon the contract awarded in June 2024 and uses...

Logo
Hybridan
410 Views
Share
bullish•Physiomics
•19 May 2025 19:06•Issuer-paid

Hybridan Research: Physiomics plc: New client, new therapeutic area

Good Morning, Physiomics PLC (PYC) announced a contract with a new UK client. We have published research on this which is attached and a snapshot...

Logo
Hybridan
430 Views
Share
bullish•Physiomics
•30 Apr 2025 00:01•Issuer-paid

Hybridan Research: Physiomics plc

Three contracts have been announced since the Interim report on 6 March and three peer reviewed scientific articles have been published so far this...

Logo
Hybridan
360 Views
Share
x